Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Universal Electronics Reports Fourth Quarter and Year-End 2025 Financial Results
-
Heritage Global Inc. Reports Fourth Quarter and Year-End 2025 Results
-
Mach Natural Resources LP Reports 109% Increase in Total Proved Reserves; Continues to Deliver Strong Distributions in 2025
-
Adobe Delivers Record Q1 Results
-
Angel Reports Fourth Quarter and Full Year 2025 Financial Results
-
AM Best Affirms Credit Ratings of Chubb Seguros de Vida Chile, S.A.
-
Ulta Beauty Announces Fourth Quarter and Fiscal 2025 Results and Provides Fiscal 2026 Guidance
-
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.
-
Funko Reports 2025 Fourth-Quarter, Full-Year Financial Results; Provides Full-Year Outlook for 2026
-
KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance
-
IHG Hotels & Resorts Recognizes Hotel Indigo Panama City Marina With Coveted “Torchbearer Award”
-
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
-
Surf Air Mobility Reports Fourth Quarter and Full Year 2025 Financial Results and Announces Guidance for 2026
-
Health Catalyst Reports Fourth Quarter and Year End 2025 Results
-
Jefferson Capital Reports Fourth Quarter and Full Year 2025 Results
-
Runway Growth Finance Corp. Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Element U.S. Space & Defense and Leonardo DRS Strike Strategic Agreement to Expand Critical EMI Testing Capabilities for U.S. Navy Systems
-
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
EverCommerce Announces Fourth Quarter and Full Year 2025 Financial Results
-
ServiceTitan Announces Fiscal Fourth Quarter and Full Fiscal Year 2026 Financial Results
-
Nine Entertainment Co. Selects Domo to Build a Unified AI and Data Foundation
-
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026
-
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
-
Silvaco Reports Fourth Quarter and Full-Year 2025 Financial Results
-
Robinhood Markets, Inc. Reports February 2026 Operating Data
-
Penguin Solutions Announces Second Quarter Fiscal 2026 Conference Call
-
Coherent Advances Scale-Across Networks with Significant Enhancements to Its Multi-Rail Transport Platform
-
Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2025 Results
-
Mission Produce® Announces Fiscal 2026 First Quarter Financial Results
-
Karat Packaging Reports Fourth Quarter and Full Year 2025 Financial Results
-
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
-
Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results
-
Crane NXT Announces Appointment of Jeffrey Benck to Board of Directors
-
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
-
IPM to Participate in the 38th Annual ROTH Conference March 22-24, 2026
-
SEABOURN INTRODUCES THE DENALI EXPERIENCE, EXTENDING ALASKA VOYAGES INTO THE HEART OF DENALI NATIONAL PARK IN 2027 AND 2028
-
Greenberg Traurig Mexico Shortlisted in The Legal 500 Mexico Awards 2026
-
Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
-
Founders Metals Upgrades Lower Antino to Advanced Target; Hits 65.9 m of 1.16 g/t Gold
-
Canadian Securities Exchange Welcomes Listing of Rise Nano Optics Ltd.
-
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
-
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
-
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
-
AGNC Investment Corp. Declares First Quarter Dividends on Preferred Stock
-
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for March 2026
-
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
Fairview Health Services Selects Workday to Modernize HR, Finance, and Supply Chain on One AI-Powered Platform
-
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
-
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
